Back to
Royal Bank of Canada
NTLA
28 quarters
Position history for
Royal Bank of Canada's holdings in Intellia Therapeutics, Inc.
Yes. Royal Bank of Canada holds 673,340 shares of NTLA (Intellia Therapeutics), worth $11.4M, as of its Q2 2026 13F filing. It increased the position by 207,841 shares (+44.7%) from Q1 2026. Royal Bank of Canada has held NTLA in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$11.4M
Current Shares
673,340
Total Value Change
+$9.6M
Total Shares Change
+541,495
Quarter-by-Quarter History
Other major holders of NTLA: ARK Investment Management LLC